NeoGenomics Inc. | Ownership
Companies that own NeoGenomics Inc.
Henderson Global Investors Ltd.
6,158,205
6.74%
-67,909
0.04%
06/30/2018
First Light Asset Management LLC
5,162,063
5.65%
401,731
9.5%
06/30/2018
BlackRock Fund Advisors
3,792,733
4.15%
113,561
0%
06/30/2018
The Vanguard Group, Inc.
2,982,569
3.26%
29,149
0%
06/30/2018
Russell Investment Management LLC
2,462,218
2.69%
-213,790
0.06%
06/30/2018
Artisan Partners LP
2,175,072
2.38%
14,583
0.03%
06/30/2018
Granite Investment Partners LLC
1,619,270
1.77%
-78,807
1.3%
06/30/2018
Emerald Advisers, Inc.
1,374,446
1.5%
108,899
0.66%
06/30/2018
Granahan Investment Management, Inc.
1,213,014
1.33%
97,040
0.88%
06/30/2018
Falcon Point Capital LLC
1,135,667
1.24%
-160,371
2.89%
06/30/2018
| Address |
12701 Commonwealth Drive
Fort Myers Florida 33913
United States
|
|
Employees
|
- |
| Website |
http://www.neogenomics.com |
| Updated |
07/08/2019 |
| NeoGenomics, Inc. provides cancer diagnostics and pharma services. It operates through a network of cancer focused testing laboratories to provide genetic and molecular testing services. It offers various testing services, including Cytogenetics, Fluorescence In-Situ Hybridization, Flow Cytometry, Immunohistochemistry, Molecular testing and Pathology consultation. |
